Výsledky vyhledávání

Meta-Analytic Review of P3 Components in Posttraumatic Stress Disorder and Their Clinical Utility

Autor: T. N. Allana, James D. Johnson, M. D. Medlin, E. W. Harris, Anke Karl

Publikováno v: Clinical EEG and Neuroscience. 44:112-134

Patients with posttraumatic stress disorder (PTSD) exhibiting disturbances in information processing, including trouble with attention, were studied. Event-related potentials (ERPs)—specifically, the P3 components (P3a, P3b, and P3 working memory {

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d82c15d0346c5b68060a03b9ea242996
https://doi.org/10.1177/1550059412469742

Zobrazit plný text záznamu

Remacemide HCl and its metabolite, FPL 12495AA, limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell culture

Autor: A W, Wamil, H, Cheung, E W, Harris, M J, McLean

Publikováno v: Epilepsy research. 23(1)

The novel anticonvulsant, remacemide HCl [(+/-)-2-amino-N-(1-methyl-1,2-diphenylethyl)acetamide monohydrochloride; FPL12924AA], and a desglycinated metabolite [(+/-)-1-methyl-1,2-diphenylethylamine monohydrochloride; FPL 12495AA] reversibly limited s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b29c027df0e1a0b16f3c742b1f90e9ce
https://pubmed.ncbi.nlm.nih.gov/8925800

Zobrazit plný text záznamu

Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia

Autor: G C, Palmer, E C, Cregan, A R, Borrelli, E W, Harris, M L, Stagnitto, P, Colombo, F C, Kaiser, R J, Murray, R C, Griffith, J C, Strand

Publikováno v: The Journal of pharmacology and experimental therapeutics. 274(2)

2-Amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) has been demonstrated to have good anticonvulsant efficacy and a relative lack of acute side effects in rodents. Similar in structure to remacemide hydrochloride, it was also shown to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::34d525f59dfead5ca586f236f8fcbd65
https://pubmed.ncbi.nlm.nih.gov/7636764

Zobrazit plný text záznamu

Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease

Autor: E W, Harris, J I, Rakow, M, Weiner, H, Agress

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 34(8)

Differentiating thymic rebound from recurrent tumor may be difficult in pediatric patients following chemotherapy for Hodgkin's disease. We present a patient who had both a negative 67Ga scan and computed tomography (CT) of the chest at diagnosis and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4351ec3351eea88ce57c6d87083272a0
https://pubmed.ncbi.nlm.nih.gov/8326394

Zobrazit plný text záznamu

Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro

Autor: G C, Palmer, E W, Harris, R, Ray, M L, Stagnitto, R J, Schmiesing

Publikováno v: Archives internationales de pharmacodynamie et de therapie. 317

Intravenous injection of N-methyl-D,L-aspartic acid (NMDLA) into mice produces characteristic convulsions followed by death. The present study was designed to determine the degree of blockade of these seizures/mortality by compounds acting at various

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e5c3be7b8e5f4583e92b3bce197aa178
https://pubmed.ncbi.nlm.nih.gov/1456842

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání